The investment will expand RNA T&T's operations and allow partners of both companies to leverage combined expertise in RNA-LNP therapeutics.

Acuitas Therapeutics shelled out an undisclosed sum to acquire a majority stake in Montreal-based and privately held RNA ...

The new findings strengthen the "RNA world" hypothesis that describes how the first life on Earth could have used RNA instead ...

RNA drugs are a new type of medicine that treat disease by influencing how cells use genetic information, rather than by ...

Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court on Tuesday for allegedly ...

A trio of mRNA molecules could help guard against the harmful effects of aging on immune cells, a study in mice finds. A new ...

Bayer's Monsanto has sued Pfizer, BioNTech and Moderna for allegedly misusing its messenger RNA technology in COVID vaccines.

A novel CRISPR defense mechanism, unlike known nucleases, specifically destroys transfer ribonucleic acids (tRNA) that are ...

The company submitted an application for a seasonal flu vaccine it believes to be a key growth driver in the years ahead.

Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...

Messenger RNA carries genetic information from DNA in the highly protected nucleus out to the rest of the cell, where structures called ribosomes can build proteins according to the DNA blueprint.